Holdings
36
Concentrated
Top 10 weight
58%
Concentration
Active share
-
Style
Equity
96%
Asset allocation
Portfolio
-Sectors
7High-conviction bets
-Top sector wt.
0.0%Cash
Market-cap allocation
Large cap31%
Mid cap22%
Small cap43%
Asset allocation
Equity96%
Top holdings
8.4%
6.7%
Aurobindo Pharma LimitedEQUITY
6.5%6.4%
Piramal Pharma LimitedEQUITY
6.0%Rubicon Research LimitedEQUITY
6.0%5.3%
4.6%
4.4%
4.2%
3.3%
Zydus Wellness LimitedEQUITY
2.8%2.4%
2.4%
2.3%
2.2%
Laurus Labs LimitedEQUITY
2.1%2.0%
1.8%
1.7%
1.7%
1.6%
1.5%
Clearing Corporation of India LtdCASH_EQUIVALENT
1.4%1.4%
Biocon LimitedEQUITY
1.4%Abbott India LimitedEQUITY
1.3%1.2%
1.0%
1.0%
1.0%
1.0%
Net Receivables / (Payables)CASH_EQUIVALENT
1.0%0.8%
0.3%
AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- Small-cap heavy (43%) - higher volatility.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
66.3%
19.3%
2.8%
2.2%
2.0%
1.2%
1.0%
1.0%
0.3%